Division of Neuromuscular Medicine, Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
J Biol Chem. 2011 May 13;286(19):17281-91. doi: 10.1074/jbc.M111.237685. Epub 2011 Mar 21.
Mutations in TRPV4 have been linked to three distinct axonal neuropathies. However, the pathogenic mechanism underlying these disorders remains unclear. Both gain and loss of calcium channel activity of the mutant TRPV4 have been suggested. Here, we show that the three previously reported TRPV4 mutant channels have a physiological localization and display an increased calcium channel activity, leading to increased cytotoxicity in three different cell types. Patch clamp experiments showed that cells expressing mutant TRPV4 have much larger whole-cell currents than those expressing the wild-type TRPV4 channel. Single channel recordings showed that the mutant channels have higher open probability, due to a modification of gating, and no change in single-channel conductance. These data support the hypothesis that a "gain of function" mechanism, possibly leading to increased intracellular calcium influx, underlies the pathogenesis of the TRPV4-linked axonal neuropathies, and may have immediate implications for designing rational therapies.
TRPV4 基因突变与三种不同的轴索性神经病有关。然而,这些疾病的发病机制尚不清楚。有人提出,突变型 TRPV4 的钙通道活性既有增加也有减少。在这里,我们表明,以前报道的三种 TRPV4 突变通道具有生理定位,并显示出增加的钙通道活性,导致三种不同细胞类型的细胞毒性增加。膜片钳实验表明,表达突变型 TRPV4 的细胞的全细胞电流比表达野生型 TRPV4 通道的细胞大得多。单通道记录表明,由于门控的改变,突变通道的开放概率更高,而单通道电导没有变化。这些数据支持这样一种假设,即“功能获得”机制可能导致细胞内钙内流增加,是 TRPV4 相关轴索性神经病发病机制的基础,并且可能对设计合理的治疗方法具有直接意义。